Drugs / Terepril
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04165174 | Dec 2019 → Nov 2020 | hepatocellular carcinoma | Huazhong University of Science and Technology | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Terepril | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04165174 ↗ |
| Modality | Monoclonal antibody | “Terepril monoclonal antibody” NCT04165174 ↗ |